Despite increasing awareness, identifying and mitigating the effects of ACEs remains a significant challenge, particularly ...

The AI-driven tools are getting better at recommending biomarker-targeted therapies, but experts warn they aren't ready for prime time.

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

Like Sarah Connor, the heroine of the Terminator movies, Elie Mystal is trying to figure out how to prepare his children for ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

FY25 Blinklab initiated an FDA registrational study of its Dx 1 platform as an aid in autism diagnosis, plus more biotech ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

This announcement is based on a press release statement from Spectral AI, and it contains forward-looking statements regarding the company's plans and expectations for the DeepView® System. These ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...